Genetic colocalisation analysis suggested that serum furin and glycoprotein Nmb were unlikely to share a causal variant with risk of breast cancer (posterior probability of a shared causal variant (H4): ≤80%, Supplemental Table S7). This evidence concerns the gene FURIN and breast carcinoma.